Hotline:
+ 49 (0) 2204 2918806
Life Sciences
Biological science comprises the whole spectrum of medical research. It includes pharmacy, health care, medical devices and diagnostics. Due to its many direct and indirect impacts, an increased focus has shifted to biotechnology during the last couple of years. Many biotech companies have developed into pharmaceutical and bio-pharmaceutical giants. The biological branch plays an important role for the majority of our society and therefore proved to be an area of particular commercial success. This also explains the strong interest in information potentially providing a strategic market advantage. This category offers diverse information on topics such as digital radiography, laboratory diagnostics, haematology, oncology etc.
Subscribe to RSS Feed

Market studies for category Life Sciences

Items 1 to 10 of 6354 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 636
  1. Net price*
    Year
  2. $4,995.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Crohn’s Disease - 5EU Drug Forecast and Market Analysis to 2022

    GlobalData
    168 pages
    The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy
    Englisch | Marktstudie | SKU: 402032
  3. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

    GlobalData
    109 pages
    GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Medullary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Medullary Thyroid Cancer. It includes an overview of the trial numbers and th
    Englisch | Zukunftsanalyse | SKU: 987680024
  4. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Moberg Pharma AB (MOB) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 pages
    Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. It specializes in developing and commercializing medical products for the treatment of skin diseases, including dry skin and bacterial and fungal infections. Moberg Derma’s products include Emtrix/Nalox for the treatment of discolored and deformed n
    Englisch | Zukunftsanalyse | SKU: 300701
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Cyprotex PLC (CRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    28 pages
    Cyprotex PLC (Cyprotex) provides a wide range of ADME-Tox contract research services for the cosmetics/personal care, pharmaceutical, and chemical industries. The company’s core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including proprietar
    Englisch | Zukunftsanalyse | SKU: 358504
  6. $3,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    EU5 Bone Densitometers Market Outlook to 2020

    GlobalData
    62 pages
    GlobalData’s new report, "EU5 Bone Densitometers Market Outlook to 2020", provides key market data on the EU5 Bone Densitometers market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market category.The report also provides company shares and distribution share
    Englisch | Zukunftsanalyse | SKU: 402935
  7. $250.00
    Für diese Studie liegt keine Bewertung vor.

    AmStem Corporation (AMST) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of AmStem Corporation provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile h
    Englisch | SWOT | SKU: 87060
  8. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of ZIOPHARM Oncology, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The prof
    Englisch | Zukunftsanalyse | SKU: 84743
  9. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    HIV-2 Infection Global Clinical Trials Review, H2, 2014

    GlobalData
    99 pages
    GlobalData's clinical trial report, “HIV-2 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-2 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-2 Infection. It includes an overview of the trial numbers and their recruitment status as p
    Englisch | Zukunftsanalyse | SKU: 987672093
  10. $2,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    France Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

    GlobalData
    270 pages
    Introduction GlobalData’s new report, “France Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others” provides key market data on the France Anesthesia and Respiratory Devices market. The
    Englisch | Report | SKU: 325471
  11. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Eylea (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022

    GlobalData
    75 pages
    The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic
    Englisch | Zukunftsanalyse | SKU: 388966

Items 1 to 10 of 6354 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 636